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Abstract
Background: The p53 gene family consists of the three genes p53, p63 and p73, which have polyhedral non-overlapping
functions in pivotal cellular processes such as DNA synthesis and repair, growth arrest, apoptosis, genome stability,
angiogenesis, development and differentiation. These genes encode sequence-specific nuclear transcription factors that
recognise the same responsive element (RE) in their target genes. Their inactivation or aberrant expression may
determine tumour progression or developmental disease. The discovery of several protein isoforms with antagonistic
roles, which are produced by the expression of different promoters and alternative splicing, widened the complexity of
the scenario of the transcriptional network of the p53 family members. Therefore, the identification of the genes
transactivated by p53 family members is crucial to understand the specific role for each gene in cell cycle regulation. We
have combined a genome-wide computational search of p53 family REs and microarray analysis to identify new direct
target genes. The huge amount of biological data produced has generated a critical need for bioinformatic tools able to
manage and integrate such data and facilitate their retrieval and analysis.
Description: We have developed the p53FamTaG database (p53 FAMily TArget Genes), a modular relational database,
which contains p53 family direct target genes selected in the human genome searching for the presence of the REs and
the expression profile of these target genes obtained by microarray experiments. p53FamTaG database also contains
annotations of publicly available databases and links to other experimental data.
The genome-wide computational search of the REs was performed using PatSearch, a pattern-matching program
implemented in the DNAfan tool. These data were integrated with the microarray results we produced from the
overexpression of different isoforms of p53, p63 and p73 stably transfected in isogenic cell lines, allowing the comparative
study of the transcriptional activity of all the proteins in the same cellular background.
p53FamTaG database is available free at http://www2.ba.itb.cnr.it/p53FamTaG/
from Italian Society of Bioinformatics (BITS): Annual Meeting 2006
Bologna, Italy. 28–29 April, 2006
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Conclusion: p53FamTaG represents a unique integrated resource of human direct p53 family target genes that is
extensively annotated and provides the users with an efficient query/retrieval system which displays the results of our
microarray experiments and allows the export of RE sequences. The database was developed for supporting and
integrating high-throughput in silico and experimental analyses and represents an important reference source of
knowledge for research groups involved in the field of oncogenesis, apoptosis and cell cycle regulation.
Background
The p53 gene family consists of the three genes p53, p63
and p73, each encoding for sequence-specific nuclear
transcription factors. p53, the first member of the family
to be identified, is involved in the maintenance of
genome integrity by transactivating genes controlling cell
growth and apoptosis in response to cellular stress signals
[1,2]. p63 and p73 have been identified as p53 homolo-
gous genes which encode proteins showing significant
similarity with p53 in the three main functional domains
(transactivation, central DNA binding and tetrameriza-
tion domains). They are able to transactivate some of the
p53-responsive genes and to induce cell cycle arrest and
apoptosis [3,4]. The p53 family members are able to bind
the same responsive element (RE), initially identified for
p53 [5,6] but with a degree of specificity for the target
genes that is quantitatively distinct.
The p53 family members have a complex transcriptional
pattern, encoding a great variety of protein isoforms. The
p53, p73 and p63 genes through alternative splicing can
produce different isoforms which differ in the C-terminal
portion (α, β, γ for p53, α, β, γ, δ, ε, and ζ for p73 and α,
β and γ for p63) [4,7-10]. Moreover, all three genes,
through the use of two alternative promoters can encode
two types of products, with or without the transactivation
(TA) domain, the latter called ΔN isoforms. Accumulating
evidence indicates that in vivo p53, p63 and p73 may be
differentially regulated and can carry out specialized, non-
overlapping functions. It has been suggested that, while
the main role of p53 lies in the inhibition of tumour pro-
gression, p73 and p63 appear to be much more strongly
involved in development and differentiation [11,12]. To
understand the specific role that each member has
acquired in cell cycle regulation, the identification of their
target genes is crucial.
We combined a genome-wide computational search of
p53 family REs and microarray analysis to identify new
direct target genes of p53 family members. In silico analy-
sis was performed using PatSearch, a pattern-matching
program implemented in the DNAfan tool (DNA Feature
Analyzer) developed in our Lab [13,14]. We optimised the
original RE consensus on the basis of criteria deduced
from experimental data to drastically reduce possible false
positive hits. Since the presence of an RE in a gene does
not imply by itself the binding and the transactivation
activity of the transcription factor, we complemented the
search of the putative p53 family transactivated genes
with DNA microarray experiments using overexpression
conditions. We investigated the transcription profiles of
the potential target genes in stable isogenic cell lines (T-
rex 293) overexpressing different members of the p53
family. This is the first study which reports microarray
results of the overexpression activity of all the three family
members in the same experimental conditions. Published
data about identification of new p53, p63 or p73 target
genes using microarray approach do not consider all three
proteins in the same study. Moreover, the Authors, within
all the up/down regulated genes of the array, only report
the RE sequences of the few genes validated by direct
binding assays [15-18]. Furthermore, these data are not
collected in relational databases accessible through the
web but in simple flat file collections with little additional
information.
The p53FamTaG database (p53 FAMily TArget Genes) was
developed to organize all the data produced by computa-
tional analysis and by microarray experiments. This data-
base is the first and unique integrated resource of human
direct p53 family target genes. It provides an efficient
query/retrieval system, is integrated with other primary
public data sources, and allows the export of the RE
sequences to be used for further in silico and experimental
analyses. Moreover, p53FamTaG contains the annota-
tions of experimental data produced in other Labs. The
structure and content of p53FamTaG will provide a valu-
able support and an important reference knowledge
source for all research groups involved in the study of
oncogenesis, apoptosis and cell cycle regulation.
Construction and content
The p53FamTaG database has been developed to organize
and integrate both the in silico and microarray data we
produced with other experimental, bibliographic and
computational annotation and to make them publicly
available and retrievable as a web resource.
Database schema
The p53FamTaG database is structured in a relational
schema using the MySQL Database Management System.
It was designed in a modular way so that data coming
from computational, experimental analyses and publicBMC Bioinformatics 2007, 8(Suppl 1):S20 http://www.biomedcentral.com/1471-2105/8/S1/S20
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resources can be easily integrated and updated independ-
ently as and when needed.
The schema consists of three main modules: the "InSilico-
Data", the "RawData" and the "ExperimentalData" mod-
ule.
The "InSilicoData" is the central module of the database
which stores the information of the target hits (REs)
obtained from in silico analysis, including: the RE
sequences structured according to the pattern (decamers
and spacers), the genomic coordinates, the genomic
regions the REs were found in (intron, promoter, 5'UTR)
and the gene names.
The "RawData" module is the repository section of the
database that only stores the raw expression data and the
experimental details of the microarray results as obtained
by the Ab1700 (Applied Biosystems) microarray reader.
This module will be important in a future version of the
database when an automatic analysis of new microarray
data will be implemented.
The "ExperimentalData" module contains the quantile
normalized data, the gene expression values obtained
from the application of statistical analysis on the microar-
ray quantile normalized data (see the Data Generation
chapter for further details), and the annotation of the
genes spotted on the microarray provided by the manu-
facturer.
It is noteworthy to mention that the schema design links
the "InSilicoData" and the "ExperimentalData" modules
of the database allowing integration between heterogene-
ous sources (see Integration data paragraph).
Data generation and database construction
In silico data
Definition of the optimal syntax pattern for the genome-wide search 
of human p53 responsive elements
The p53 Responsive Element (RE) is made up of two tan-
dem repeated decamers complying with a specific consen-
sus corresponding to the 5'-PuPuPuC(A/T)(T/
A)GPyPyPy-3' sequence, allowing at most 3 mismatches.
The decamers can be spaced by 0 to 13 nt and are gener-
ally located in the promoter region, or in the first introns
of transactivated genes [6]. The same consensus is also rec-
ognised by p63 and p73. This consensus appears to be rel-
atively non-stringent for transcription factors with such
profound biological effects and produces huge numbers
of hits located at any positions within the genome. In
order to reduce the number of hits and to enhance the
selectivity of the pattern searching analysis in a genome-
wide search, we optimised the original RE consensus by
introducing new criteria of stringency based on the com-
parative analysis of 109 human experimentally demon-
strated REs contained in 83 target genes of the p53 family
members. These genes have been demonstrated to be
direct targets by different methodological approaches
(measurements of transactivation activity, EMSA, Chro-
matin immuno-precipitation) (for references, the book-
buttons in the database provide the link to PubMed).
To highlight the structural features of these 109 REs we
considered: 1) the conservation of each specific position
in the two decamers, 2) the spacer length between the
decamers, 3) the position of the REs with respect to the
transcription start site (TSS), and 4) the presence of addi-
tional decamers.
To compute the degree of conservation of each specific
position in the two decamers we performed a multiple
alignment of these sequences (excluding the spacers
between the decamers) and applied the Consensus pro-
gram of RSA-Tools (Regulatory Sequence Analysis Tools)
which produces a probabilistic description of the
sequences based on PWMs (Position Weight Matrices).
Interestingly, we found that 95% of the p53 REs have up
to 8 spacer bases (sb). In particular, 62% have up to 2 sb
and no RE has 12 or 13 sb. The analysis of the RE location
relative to the TSS of the target genes as mapped in
ENSEMBL revealed that: 50 out of 51 known REs identi-
fied in the promoter regions, were located within 3500 bp
upstream of the TSS, and 52 out of 58 known REs identi-
fied in the introns were present within 20,000 bases
downstream of the TSS.
To further increase the accuracy of RE prediction we also
searched for additional decamers. Indeed, other studies
have reported that the canonical p53 target sequence may
include additional decamers where up to 3 mismatches
are allowed [5]. By using the PatSearch program [14] to
search for a pattern following the criteria mentioned
above including a third decamer, we found an additional
third decamer very often not observed by the Authors,
within all the 83 experimentally demonstrated p53 target
genes.
In conclusion, on the basis of experimental data we lim-
ited the search analysis for p53 gene family REs, to a
region ranging from -3500 (in the promoter region) to
+20000 (in intron regions) with respect to the gene TSS.
In this search we included the 5'UTR and excluded the
annotated coding exons. We modified the consensus syn-
tax including 3 decamers spaced by 0 to 8 bases, allowing
up to 3 total mismatches in two adjacent decamers, toler-
ating up to 3 mismatches in the third decamer. A post-
processing phase of PatSearch matching the inferred PWM
(Figure 1A) was also carried out (see below). The sequenceBMC Bioinformatics 2007, 8(Suppl 1):S20 http://www.biomedcentral.com/1471-2105/8/S1/S20
Page 4 of 12
(page number not for citation purposes)
logo of the p53RE derived from the PWM is shown in Fig-
ure 1B.
Search of the p53 responsive elements in the human genome
The computational analysis to identify the human REs
was performed using the PatSearch algorithm imple-
mented in the DNAfan tool [13,14]. DNAfan filter facili-
ties allow the user to analyze specific genome regions (e.g.
promoter regions, 5'UTR, introns, etc.). The program
therefore automatically generates on feature key annota-
tion, a specific sequence dataset spanning a given feature
key on which the desired analysis program, in our case
PatSearch, is executed. PatSearch is particularly suitable
for searching sequence data for the presence of complex
oligonucleotide patterns, the structure of which was
derived from experimental characterization of functional
elements. Using the syntax pattern previously described
(Figure 1A), we performed a genome-wide search in the
ENSEMBL database (release 34) and found 63384 REs in
18.110 genes, after redundancy cleaning based on their
absolute genome coordinates.
The relevant information contained in DNAFan output,
including the sequence of the REs, the pattern structure
according to the specific syntax (decamers, spacers), and a
set of genomic information such as ENSEMBL gene ID
(ENSG), gene name (HUGO nomenclature), chromo-
some, strand direction and absolute start site, was
uploaded into the "InSilicoData" tables of the database
using a perl script.
Figure 2 reports the genome wide description of the distri-
bution of REs in non-translated genomic sequences (pro-
moters, 5'UTRs and introns). The highest density of REs is
concentrated in the TSS upstream regions (promoters)
and slightly decreases along the intron sequences, propor-
tionally to the downstream distance from the gene TSS.
Interestingly, a significant reduction in RE frequency is
evident in the region immediately downstream of the TSS
corresponding to the 5'UTRs. This distribution trend is
coherent with the localization of known experimentally
validated REs, further supporting the validity of our in sil-
ico search criterion.
Microarray data
The in silico analysis was complemented by an experimen-
tal microarray approach. In order to examine the conse-
quences of the overexpression of different members of the
p53 family on their target genes under comparable condi-
tions, we created human embryonic kidney Flp-In T-Rex-
293 stable isogenic cell lines expressing the different genes
under the control of tetracycline inducible promoter. As a
control we created a stable cell line containing CAT (Chlo-
ramphenicolo acetyl transferase) cDNA. For microarray
hybridization, mRNA was extracted from cell lines at 6 h,
24 h after induction of the different proteins and 20 μg
were labeled by retrotranscription and hybridised to the
microarray (Applied Biosystems Human Genome Survey
Microarray V1.0 containing 33202 probes for the interro-
gation of 27686 genes) according to the protocols sup-
plied by the manufacturer (Applied Biosystems).
The resulting data set consists of 6 different experimental
conditions (Flp-In T-Rex-293 cells stably transfected with:
p53, p53R175H, TAp63α,  ΔNp63α, TAp73α, TAp73β)
analysed in two technical replicas probed at two different
time points (6 and 24 h) and two technical replicas of the
control experiment. Therefore we processed the data gen-
erated from 26 microarrays.
The expression values (raw data) including statistical
quality measurements for each microarray were obtained
as exports from the Ab1700 (Applied Biosystems) soft-
ware. Quantile normalization, using the statistical soft-
PatSearch syntax and Sequence logo of the p53RE Figure 1
PatSearch syntax and Sequence logo of the p53RE. A) 
PatSearch syntax for the in silico search of the p53 gene family 
REs including the two decamer PWM. B) Sequence logo of 
the p53RE derived from the PWM.BMC Bioinformatics 2007, 8(Suppl 1):S20 http://www.biomedcentral.com/1471-2105/8/S1/S20
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Distribution of the REs Figure 2
Distribution of the REs. Distribution of the database set of 63890 REs, over a 100 nt window, along the human genomic 
sequence from -3500 nt upstream to 20000 nt downstream of the gene transcription start site (TSS). There is an evident signif-
icant reduction in frequency of the REs in the region immediately downstream of the TSS corresponding to the 5'UTRs.BMC Bioinformatics 2007, 8(Suppl 1):S20 http://www.biomedcentral.com/1471-2105/8/S1/S20
Page 6 of 12
(page number not for citation purposes)
ware package R, were performed on the whole expression
data set (~33000 probeID × 26 microarrays) to obtain
entirely comparable data within and between microar-
rays. The raw data including the statistical quality meas-
urements were uploaded into the "RawData" tables of the
database using a perl script saving the raw signal, assay-
normalised signal, signal to noise (S/N), and the flag
value. For every array design we also had to parse and
upload the annotation of the corresponding genes spotted
on the microarray provided by the manufacturer. The
algorithm's quality metrics flags and the ratio of S/N were
used to quantify probe quality and "detectability" in each
sample-control comparison (1700 Chemiluminescent
Microarray Analyzer Users Guide). Only probes with
<5000 flags in both replicas and S/N ≥ 3 in at least one
replica in both sample and control were positively filtered
and used for successive statistical analysis.
In the subsequent step of data analysis, a tool based on a
Bayesian statistical framework, CyberT, was applied to
compare normalized expression values of filtered probes
between each sample and control. The tool allows the
identification of differentially expressed genes with a
higher level of confidence than a simple t-test, when only
few experimental replicates are available, and implements
a posterior probability of differential expression-based
method (PPDE(<p)) for calculating the global false-posi-
tive and false-negative levels [19].
Microarray probes were classified as differentially
expressed, in each sample-control comparison, if
PPDE(<p) >0.995 (posterior probability of differentially
expressed genes). This threshold corresponds to log trans-
formed Bayesian p-value thresholds, which are different
in each experiment, but always lower than 0.0032. For
these probes, fold change was reported as S/C (when S>C)
or -C/S (when C>S) where S is the sample expression
value and C is the control expression value. Probes that
were not significantly up or down regulated and those
negatively selected in the filtering step were also identified
and reported without fold change indication.
The quantile normalized expression data used for the sta-
tistical analysis and the Cyber-T results (fold-change,
Bayes.lnp and the PPDE (<p)) were uploaded into the
"ExperimentalData" tables using a perl script. Cyber-T
results can be easily recalibrated by changing the cut-off
values.
Data integration and annotation
Due to the heterogeneity of the data sources we used to
produce the in silico and experimental results and the
absence of a standardized annotation between them, the
most complex task was linking the modules. In particular,
the in silico data were referred to ENSEMBL annotation
(loaded in the "InSilicoData" module) and the gene
expression data were referred to the Ab1700 (Applied Bio-
systems) microarray chip annotation extracted from the
CELERA Panther© system (loaded in the "Experimental-
Data" module). To link these two data sets, we extracted
the RefSeq accession number and the HUGO gene names
from the microarray annotation and linked them to the
ProbeID which is the unique identifier of the probe on the
microarray chip. In parallel, for the ENSG of each gene
containing the RE, the RefSeq accession number and the
HUGO gene names were extracted from ENSEMBL. A sim-
ple link was established by the comparison and a succes-
sive association, implemented by iterative SQL statement,
between REs and microarray spots (ProbeID) having the
same Gene name and Refseq accession number in the two
data sets. In this way we established 17644 links between
the in silico data and the spotted genes on the microarray.
However, only 4874 genes, which contain the REs, have a
significant microarray result in at least one experimental
condition.
Each gene stored in the database has extensive annotation
extracted from different public resources such as:
ENSEMBL Gene ID, gene name and aliases, RefSeq acces-
sion number, Celera gene ProbeID.
The p53FamTaG database also annotates other experi-
mental data produced in different labs. In particular, the
83 genes stored in the database that were experimentally
demonstrated as direct target genes by other Authors, are
linked through PubMed to the abstract of the paper
reporting the data. Moreover, 341 p53 high-confidence
binding loci obtained using the genome wide ChiP-PET
approach reported in a recent paper [20] have been anno-
tated in the database and linked to PubMed and to UCSC,
where the annotation can be found in the ENCODE Chro-
matin Immunoprecipitation tracks under the p53 ChiP-
PET analysis (GIS p53 5 FU HCT116 Track Settings).
A summary of the database content is reported in Table 1.
Utility
The complexity of the schema and the quantity of infor-
mation stored in the database, represented a challenge in
terms of visualisation and navigation.
The p53FamTaG database is freely available through a
web-application developed in PHP (Seagull framework)
and can be queried in a user-friendly manner through a
graphical user interface (GUI). Wizard-like steps were
developed to drive the user into the navigation.
A horizontal menu bar provides links to the Home page,
Search form and on-line users' Manual.BMC Bioinformatics 2007, 8(Suppl 1):S20 http://www.biomedcentral.com/1471-2105/8/S1/S20
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The 'Search' form (Figure 3) allows the users to search the
database for p53 gene family target genes. The search cri-
teria are ENSEMBL and RefSeq idenfiers, HUGO or alias
gene names. All search fields accept lists of items sepa-
rated by a comma and execute the search in OR mode
(case study: bax, fdxr, mdm2, pank1).
The query report (Figure 4) lists the matching database
records ordered by ENSG. It reports the gene and alias
name, ENSEMBL stable gene ID (ENSG), RefSeq accession
number, the gene region where the RE was found (intron,
5'UTR, promoter), the chromosome, the strand orienta-
tion and the number of possible target sites (REs column).
The gene name, the ENSEMBL ENSG and the RefSeq ID
are hyperlinks to the HGNC, ENSEMBL and RefSeq data-
bases, respectively. A magnifying glass-button, in the array
column, provides a link to microarray data, while the
book-button in the Gene name column allows the
PubMed reference to be consulted for the experimentally
demonstrated target genes. The UCSC-button in the
UCSC column links genes identified by ChIP-PET analysis
to the UCSC database. Moreover, a hyperlink of the hit
number, in the REs column, leads to more detailed infor-
mation about the different hit/REs including the genomic
coordinates, the size and a graphical representation of the
target sequence depicting the pattern (decamers and spac-
ers) (Figure 5). From this page it is possible to easily
export the selected RE sequences in FASTA format, with
the indication of the decamers and spacers, and the exact
genomic coordinates (Figure 6).
When the ENSG of interest has a result in the microarray
data, a link leads the user to the expression data of the
gene. The new page visualises the expression profile of this
gene (for each Celera probe ID representing a gene on the
array) in all the stable isogenic cell lines (Figure 7) with
graphical icons. The results of the gene expression are
indicated as "Up regulated", "Down regulated", "Not sta-
tistically significant" or "Negatively filtered". "Up regu-
lated" is the fold change value reported as S/C (when S>C)
while "Down regulated" is the fold change value reported
as -C/S (when C>S), where S is the expression value of the
gene in the Sample, and C is the expression value of the
gene in the Control. "Not statistically significant" indi-
Database query form Figure 3
Database query form. This form allows the users to search the database for p53 gene family target genes. The search crite-
ria are ENSEMBL and RefSeq idenfiers, HUGO or alias gene names. All search fields accept lists of items separated by a comma 
and execute a search in OR mode. The database has been queried for the BAX, FDXR, MDM2 and PANK1 genes.
Table 1: Database Content
Genes containing REs 18110
REs in promoters 13649
REs in 5'UTRs 563
REs in introns 49678
Microarray data of genes containing the RE 4874
Experimentally demonstrated target genes 83
ChiP-PET high-confidence binding loci 341BMC Bioinformatics 2007, 8(Suppl 1):S20 http://www.biomedcentral.com/1471-2105/8/S1/S20
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cates expression values with PPDE(<p) <0.995 and "Neg-
atively filtered" indicates expression values filtered out by
quality control (flag >5000 and signal to noise S/N < 3).
In conclusion, the user can query the database to find out
whether or not a gene of interest contains a p53 gene fam-
ily RE and how this gene is expressed under overexpres-
sion of the three members of the p53 gene family in 293
T-rex cells.
Discussion
The recent explosion of "knowledge production" due to
the completion of human genome sequences and to the
availability of high-throughput technology (such as
microarray, ChIP-PET, Chip-on-Chip) has generated a
critical need for bioinformatic instruments able to man-
age the huge amount of biological data produced and to
facilitate their retrieval and analysis. Moreover, the inte-
gration of data from different resources, such as in silico
analysis, experimental data and biological databases, is
crucial to exploit the large amount of information availa-
ble and to focus on the discovery of the functional role of
genes, and their expression regulation.
The p53FamTaG database is a comprehensive and unique
resource of genome-wide search of human p53, p63, p73
direct target genes combining the in silico prediction of
their p53 REs, with the transcriptional profiles of these
target genes in isogenic cell lines over-expressing different
members of the p53 family. The dissection of the tran-
scriptional targets of p53 gene family members, which
recognise the same RE, is a challenge in cancer research.
p53 is mutated in over 50% of all cancers and in the
remaining cases its pathway may also be affected. The
involvement of p73 and p63 in tumour development is
much less well-established. Multiple isoforms of p63 and
p73 have been characterised and emerging evidence sug-
gests that some of the roles played by the TAp63 and
TAp73 isoforms overlap those of p53, whereas their ΔN
variants have an opposite effect or even an oncogenic role
in cancer progression.
To identify putative direct target genes of the p53 gene
family, we performed an in silico genome-wide search of
the p53 REs in specific regions of the human genes (pro-
moter region, introns, 5'UTRs), using criteria defined on
the structure of 109 REs of 83 human experimentally
demonstrated target genes. Through this in silico search we
selected 18110 human genes containing the REs as poten-
tial p53 family direct target genes.
We complemented and validated the in silico results with
the study of the expression profile of these potential direct
target genes using the microarray approach. To this pur-
Query result page Figure 4
Query result page. Results are displayed as a table summarising information on retrieved entry. The Gene Name, ENSG 
entry and NM entry are linked to the HGNC, ENSEMBL and RefSeq databases respectively. The clickable book provides access 
to PubMed for the transactivated genes (BAX, FDXR, MDM2) and for ChIP-PET high confidence binding loci (BAX) references. 
The Array button, when pressed, shows the microarray results (Fig. 7), the UCSC button activates the link to the annotation in 
UCSC of ChIP-PET binding loci (BAX). The alias gene name, the number of REs, the gene region localization, the strand orien-
tation, and the chromosome also are reported. The REs button shows the number of the hits and, when pressed, more 
detailed information (Fig. 5).BMC Bioinformatics 2007, 8(Suppl 1):S20 http://www.biomedcentral.com/1471-2105/8/S1/S20
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pose we generated stable transfected cell lines integrating
the expression constructs of p53, TAp63α,  ΔNp63α,
TAp73α, TAp73β and the p53R175H mutated isoform in
the same genomic locus. This allowed us to examine, in
the same cellular context, the effects of the overexpression
of p53 family members on the expression profile of the in
silico detected direct target genes.
In recent years, distinct studies have aimed to identify
p53, p63 and p73 regulated genes using DNA microarray
approaches. However, all the three proteins have not be
analysed so far in the same study and considering the het-
erogeneity of experimental and genetic backgrounds used
(cellular stressors, cell lines, etc), it is very difficult, if not
impossible, to compare the expression profiles of those
independent studies to identify common and non-com-
mon target genes and whether those genes are direct or
indirect targets [15-18]. A further drawback of these
results is that they exists only as simple flat files, poorly
annotated and they are not collected in relational data-
bases publicly available through the web.
p53FamTaG database was designed to store the informa-
tion of the in silico and microarray approaches with links
Details of the REs of one ENSG Figure 5
Details of the REs of one ENSG. The table shows the gene information at the top and below the number and list of hits 
(REs) reporting the chromosomal position, size, strand orientation and the gene region localization, as well as a graphical rep-
resentation of the target sequence depicting the pattern (decamers and spacers). The Select/Deselect buttons allow the selec-
tion of RE sequences for export (Fig. 6).BMC Bioinformatics 2007, 8(Suppl 1):S20 http://www.biomedcentral.com/1471-2105/8/S1/S20
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between the two data sets and to the most accredited data-
bases world-wide. Through a user-friendly graphical inter-
face, it is possible to query this complex information in a
few seconds. For each gene containing the RE, the data-
base provides the gene name (HUGO), the alias name, the
ENSEMBL stable gene ID and RefSeq ID, the chromo-
some, the RE structure (decamers, spacers, length,
sequence), the RE chromosomal position and gene region
localization (promoter, 5'UTR, intron) and the microar-
ray results. Moreover, the database provides the hyperlink
to PubMed for the experimentally demonstrated target
genes.
One particularly noteworthy feature of the database is the
possibility to export the sequences of the REs including
full information in FASTA format, which is not possible
from any other public resource. The availability of the RE
sequences of potential target genes which appear to be up
or down regulated in our microarray experiments, allows
to guide experimental approaches (such as PCR amplifica-
tion of REs and cloning for luciferase, EMSA, Chromatin
immuno-precipitation assays) to demonstrate the binding
of the p53 family member to the RE (manuscript in prep-
aration). Furthermore, these results may lead to refining
the specific RE for each p53 family member and finally to
Details of Microarray results Figure 7
Details of Microarray results. The Microarray data were obtained by the overexpression of wild type p53, p53 mutated 
form p53R175H, TAp73α, TAp73β, TAp63α, ΔNp63α, at 24 h and 6 h. The table shows the Celera Probe ID, detecting the 
gene on the array, and the fold change values of the up/down regulated gene in each cell line. The symbols on the bottom link 
to the Manual for details of expression data analysis.
RE Sequence export form Figure 6
RE Sequence export form. Export form of the selected RE sequences in FASTA format, with the indication of the decamers 
and spacers, and the exact genomic coordinates.BMC Bioinformatics 2007, 8(Suppl 1):S20 http://www.biomedcentral.com/1471-2105/8/S1/S20
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identifying common transcription binding site frame-
works by applying algorithms.
An additional significant feature of p53FamTaG database
is the annotation of 83 experimentally demonstrated
direct target genes integrated with the microarray data
produced in our Lab. These target genes are often only val-
idated for one of the members or isoforms of the p53 fam-
ily members. Our data set now allows the user to observe
such a target gene under the overexpression of the three
p53 family members under identical experimental condi-
tions and to understand the involvement of each member
in the modulation of this target gene.
A map of 542 human p53 high-confidence binding loci,
obtained by ChIP (chromatin immunoprecipitation)-PET
(paired-end ditag) approach, has recently been published
[20]. The PET sequences are derived from about 66,000
individual p53 ChIP fragment sequences using human
HCT116 colorectal cancer cells treated with 5-fluorouracil
for 6 h, conditions known to activate p53 expression. The
gene name, the sequence and the chromosomal localiza-
tion of the 542 binding loci PET clusters are available in
the UCSC database. However, the REs are not indicated
and therefore not suitable for further studies. Out of the
542 loci, only 381 corresponded to known genes with the
others referring to sequences lacking gene names, to
cDNA clones or to hypothetical proteins. We queried our
p53FamTaG database by using the list of these 381 gene
names and we found that 341 genes are present in our
database, showing that our pure in silico approach found
most of these experimentally selected RE. Moreover, for
205 of these target genes our database reports the micro-
array results, making available for these genes, studied
only for p53, also the transcriptional effect of p53R175H,
TAp63α, ΔNp63α, TAp73α and TAp73β under our exper-
imental conditions.
The availability of a database like p53FamTaG able to
integrate, retrieve and display this precious information
also led us to find a way to include the ChIP-PET data
through a link to the UCSC database.
It should be considered that high throughput technology
(microarray, ChIP-PET, Chip-on-Chip) has the advantage
of producing and analysing large quantities of biological
data, yet it is based on robust experimental methodology
(which also has a substantial cost) and statistical analysis.
However, each experiment in any case remains referred to
specific conditions (type of inductors, cellular stressors,
cell line), and represents an initial framework for further
experimental validation more focused on particular cellu-
lar conditions. In particular, in gene expression studies,
among the regulatory elements (p53 family members REs
in our case) spread throughout the genome, only some are
involved in specific conditions following binding dynam-
ics or tissue specificity of the transcriptional network. For
example, out of the 83 direct target genes that have been
experimentally demonstrated and are annotated in our
database, only 15 genes were identified in the global map
study with the ChIP-PET approach reporting 542 p53
binding sites.
With the global in silico search the p53FamTaG database is
able to collect all the information and put it into a holistic
picture creating new knowledge that would not be possi-
ble on a single data set. Therefore, p53FamTaG represents
a powerful resource and may be considered a basic repos-
itory colligating existing information for researchers in
this field. The database content is reported in Table 1. The
validity of the in silico data we obtained by applying DNA-
fan and in particular the consistence of the criteria we
established for the genome-wide RE search (stringency
and complexity of the search pattern) were supported by
the positive selection of 83 experimentally demonstrated
p53 target genes and of 341 ChiP-PET high-confidence
binding loci reported in literature. Moreover, the majority
of the published target genes present in p53FamTaG have
a statistically significant change of expression in at least 1
sample of our experimental conditions. These results
strongly validate the complementary approach between
the in silico search and the microarray experiments.
The important features of the structure of the database are:
1) its design in modules so that, with the perspective of
data integration, it can be easily extended to host addi-
tional data such as new experimental data (results from
microarray or real-time PCR approaches), and data from
the literature, making the new data available in context
with the target sequence analysis; 2) the design can be
mirrored for example for the identification and collection
of the REs in other organisms or for the in silico identifica-
tion of other transcription factor binding sites.
Conclusion
The p53FamTaG database is the first and only available
publicly resource developed for supporting and integrat-
ing high-throughput in silico and experimental analyses of
p53 family target genes and represents an important refer-
ence source for research groups involved in the fields of
oncogenesis, apoptosis and cell cycle regulation.
p53FamTaG includes a wide number of human genes
(18,110) containing the REs obtained from a large-scale
human genome analysis, based on criteria derived from
experimental conditions. Information stored in the data-
base can be easily queried by searching for a particular
gene of interest or for a dataset of genes produced by other
methodologies (e.g. a list of genes up/down regulated in
other microarray studies) for the identification of novel
direct p53 family target genes.BMC Bioinformatics 2007, 8(Suppl 1):S20 http://www.biomedcentral.com/1471-2105/8/S1/S20
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This strategy of combining in silico and experimental
approaches and the possibility to compare different meth-
odological approaches as well as the effect of the wild-type
and oncogenic isoforms may allow the reconstruction of
the comprehensive p53 family downstream network and
will be of great help in elucidating the particular defects in
the p53 family response associated with human cancers
thus generating new tools for diagnostic, medical and
pharmacological applications.
Availability and requirements
p53FamTaG database is publicly available at [21]. The
e_mail bigstaff@ba.itb.cnr.it may be used for questions,
comments, suggestions and corrections.
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